Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
15 September 2021Website:
http://www.pasithea.comNext earnings report:
20 November 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Tue, 19 Nov 2024 21:00:00 GMTDividend
Analysts recommendations
Institutional Ownership
KTTA Latest News
Pasithea completes chronic toxicity studies for PAS-004, showing safety and potential for long-term use in NF1 and cancer treatment; Phase 1 trial ongoing
Pasithea Tx appoints Dr. Rebecca Brown, an expert in Neurofibromatosis and Director at Mount Sinai, to its Scientific Advisory Board to aid in PAS-004.
Pasithea Therapeutics (NASDAQ: KTTA ) stock is falling on Wednesday after the company's shares experienced major volatility on Tuesday. Investors watching KTTA stock will note that it closed out Tuesday up less than 1%.
-- Attendees may request 1 x 1 meeting with management at [email protected] -- PALO ALTO, Calif. and MIAMI, Fla., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research, and development of innovative treatments for central nervous system (CNS) disorders, announced today that Pasithea's management team will participate in the H.C. Wainwright 25th Annual Global Investment Conference, to be held in New York City, September 11-13.
What type of business is Pasithea Therapeutics?
Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
What sector is Pasithea Therapeutics in?
Pasithea Therapeutics is in the Healthcare sector
What industry is Pasithea Therapeutics in?
Pasithea Therapeutics is in the Biotechnology industry
What country is Pasithea Therapeutics from?
Pasithea Therapeutics is headquartered in United States
When did Pasithea Therapeutics go public?
Pasithea Therapeutics initial public offering (IPO) was on 15 September 2021
What is Pasithea Therapeutics website?
https://www.pasithea.com
Is Pasithea Therapeutics in the S&P 500?
No, Pasithea Therapeutics is not included in the S&P 500 index
Is Pasithea Therapeutics in the NASDAQ 100?
No, Pasithea Therapeutics is not included in the NASDAQ 100 index
Is Pasithea Therapeutics in the Dow Jones?
No, Pasithea Therapeutics is not included in the Dow Jones index
When was Pasithea Therapeutics the previous earnings report?
No data
When does Pasithea Therapeutics earnings report?
The next expected earnings date for Pasithea Therapeutics is 20 November 2024